Résumé
Chinese Pharmacopoeia (2015 edition) recorded that Corydalis Rhizoma and Corydalis Decumbentis Rhizoma are derived from the genus Corydalis, sexual taste similar efficacy, but the actual clinical application of the focus is different. In this paper, the research progress of the two kinds of Chinese materia medica (CMM) is summarized from the three aspects of herbal research, chemical composition, and pharmacological action, which can provide reference for the identification and clinical application of the two drugs. Based on the core concepts of Q-marker, Q-marker components of Corydalis Decumbentis Rhizoma are forecasted and analyzed from original source, efficacy, pharmacokinetics, in vivo process, and the traditional drug property, which provides a theoretical basis for the establishment and improvement of the quality standard of medicinal materials.